Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: sorption

April 22, 2024 Environmental / Non-pharma applications

Stepwise Design of a Lab PROTOTYPE for the Removal of Emerging Contaminants in Water Using Cyclodextrin-Epichlorohydrin Polymers as Adsorbent Material 

This study shows the results of the operational design to build a prototype for the retention at lab scale of

Continue reading

September 16, 2022 Environmental / Non-pharma applications

Carbamazepine Removal from Water Using Cyclodextrin-polymers Bearing Titanium Dioxide

The antidepressant carbamazepine (CBZ) is one of the most frequently detected chemical compounds in urban water [1]. Water insoluble cyclodextrin

Continue reading

July 15, 2020 CD as API / CD derivatives

Cyclodextrin nanosponges for organic toxic molecule removal

Chronic Kidney Disease (CKD) is a global health problem that causes serious economic burden for countries and patients, besides having

Continue reading

September 18, 2019 Environmental / Non-pharma applications

Removal of hazardous micropollutants from treated wastewater using cyclodextrin bead polymer – a pilot demonstration case

Increasing amount of micropollutants such as drugs, cosmetics and nutritional supplements detected in surface waters represents increasing risk to humans

Continue reading

November 22, 2018 CD derivatives / Environmental / Non-pharma applications

Self-decontaminating biocatalyst against nerve gases

Chemical warfare agents (CWA) are one of the most brutal weapons  created by mankind [1]. CWAs are inexpensive and are

Continue reading

Recent Posts

  • Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (355)
  • CD derivatives (431)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (816)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (416)
  • Other industrial use (112)
  • Pharma applications (1,219)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • Special Issue titled "Cyclodextrins: Properties and Applications, 4th Edition"
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • Cyclodextrin-assisted drug delivery to Central Nervous System: Mavenclad™ for multiple sclerosis treatment
  • Lanosterol eye drops for cataract treatment
  • Cyclodextrins and derivatives in drug delivery: New developments, relevant clinical trials, and advanced products
  • Smart Materials and Surfaces - SMS 2026 International Conference

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...